UPDATE : Friday, October 18, 2019
상단여백
ISU Abxis’ US partner to start P2b trials of hemophilia B treatment
ISU Abxis said Friday that Catalyst Biosciences, its U.S. partner, has begu...
by Lee Han-soo  |  2019-04-05 16:16
라인
Gemvax & Kael’s wins nod for P3 trial of benign prostatic hyperplasia treatment
Gemvax & Kael said Friday that the Ministry of Food and Drug Safety has app...
by Lee Han-soo  |  2019-04-05 14:49
라인
Handok, CMG apply for P1 trial for anticancer treatment candidate
Handok and CMG Pharmaceutical said they have applied to the Ministry of Foo...
by Lee Han-soo  |  2019-04-05 12:23
라인
Court suspends ministry’s disciplinary action against Dong-A ST
The Seoul Administrative Court Wednesday suspended the Ministry of Health a...
by Lee Han-soo  |  2019-04-04 16:55
라인
Corestem’s Lou Gehrig disease treatment becomes orphan drug in EU
Corestem said Wednesday that NeuroNata-R, its Lou Gehrig's disease ther...
by Lee Han-soo  |  2019-04-04 15:25
라인
Genexine, NeoImmuneTech release 2 clinical trial results at AACR
Genexine and NeoImmuneTech said Thursday that they have presented two poste...
by Lee Han-soo  |  2019-04-04 14:16
라인
GC, Clinigen K.K. ink licensing accord for Hunter syndrome drug
GC said Thursday that it has signed an exclusive licensing agreement to com...
by Lee Han-soo  |  2019-04-04 11:19
라인
Fate of Kolon Life Science hangs on Invossa-K test results
The drug authorities will decide the level of a sanction against Kolon Life...
by Lee Hye-seon  |  2019-04-03 18:14
라인
[Special] MSD Korea makes wrong excuse on external monitoring
After Korea Biomedical Review’s exclusive report revealed that MSD Korea co...
by Jeong Sae-im  |  2019-04-03 16:59
라인
GC releases preclinical trial results for immunotherapy candidate at AACR
GC said Wednesday that it has presented the preclinical trial results of MG...
by Lee Han-soo  |  2019-04-03 14:18
라인
Qurient displays immunotherapy candidate at AACR
Qurient said Wednesday that it held a poster session to present the preclin...
by Lee Han-soo  |  2019-04-03 14:18
라인
Kang becomes new CEO of Abbvie Korea
Abbvie Korea said Monday that it has appointed Kang So-young as its new gen...
by Lee Han-soo  |  2019-04-03 10:50
라인
Lilly’s migraine-preventing therapy becomes orphan drug here
The Ministry of Food and Drug Safety (MFDS) announced Monday that it has gi...
by Lee Han-soo  |  2019-04-02 16:09
라인
‘Paternity testing’ would have prevented Invossa debacle
Kolon Life Science’s mislabeling one of the ingredients of Invossa-K, gene ...
by Jeong Sae-im  |  2019-04-02 15:27
라인
[Special] MSD Korea asks monitoring agents to record talks ‘discreetly’
MSD Korea’s Self-Assurance program initially aimed to ensure legitimacy, tr...
by Jeong Sae-im  |  2019-04-02 14:45
라인
Kolon apologizes for ‘mislabeled’ ingredient in Invossa
Kolon Life Science apologized Monday for “mislabeling” one of its key compo...
by Lee Han-soo  |  2019-04-01 17:35
라인
ST Pharm unveils pre-clinical trial results for HIV treatment
ST Pharm said Monday that it has presented the pre-clinical trial results f...
by Lee Han-soo  |  2019-04-01 15:39
라인
Argatroban raises bleeding risk in pregnant women
The Korean regulator would add a precaution label to argatroban, a treatmen...
by Lee Hye-seon  |  2019-04-01 15:29
라인
Hanmi launches seborrheic dermatitis treatment
Hanmi Pharmaceutical said Monday that it has launched Dupien, a seborrheic ...
by Lee Han-soo  |  2019-04-01 14:24
라인
[Special] Why doctors got upset with MSD Korea’s monitoring program
MSD Korea said it was running the Self-Assurance program to ensure legitima...
by Jeong Sae-im  |  2019-04-01 14:22
여백
여백
여백
Back to Top